期刊文献+

清肺利湿解毒方药治疗痤疮的临床观察及对血清相关性激素水平的影响 被引量:5

Clinical Observation of Lung-Clearing,Dampness-Eliminating and Toxicity-Removing Formulations in Treating Acne Valgaris and change of Sexhormone
下载PDF
导出
摘要 目的评价清肺利湿解毒方药治疗寻常性痤疮的疗效及安全性,并观察其对痤疮患者性激素的调节作用。方法 100例寻常性痤疮患者内服本科自拟清肺利湿解毒中药方治疗8周,评价其临床疗效及安全性,并观察50例患者治疗前后外周血中睾酮(T)、雌二醇(E2)、黄体生成素(LH)、促卵泡素(FSH)、催乳素(PRL)、孕酮(PRG)的变化。结果临床治愈38例(38.0%),显效47例(47.0%),有效率为85.0%,无不良反应。其中女性痤疮患者的T及PRL水平治疗前后有显著变化(P<0.05),男性患者激素水平治疗前后均无明显变化(P>0.05)。结论清肺利湿解毒方治疗寻常性痤疮具有明显的临床疗效,且无不良反应,其可能通过调节机体性激素水平达到治疗寻常痤疮的目的 。 Objective To evaluate the clinical efficacy and the safety of Lung-Clearing, Dampness-Eliminating and Toxicity-Removing Formulations in treating Ache Valgaris and investigate the change of the sexual hormone. Methods One hundred patients of Acne Valgaris took Lung-Clearing, Dampness-Eliminating and Toxicity- Removing Formulations. The clinical efficacy, safety and the change of level of follicle stimulating hormone ( FSH ) , luteinizing hormone (LH) , testosterone (T) , estradiol ( E2 ) , prog (P). prolactin (PRL) in 50 patients 'after 8 weeks were assayed. Results Thirty-eight patients (38.0%) were cured,47 cases (47.0%) showed markedly effective, and total effective rate was 85.0%, No adverse reactions occurred. T and PRL level in women with acne changed significantly before and after treatment(P 〈0.05), and hormone levels in men showed no significant change ( P 〉 0. 05 ). Conclusions Clinical efficacy of Lung-Clearing, Dampness- Eliminating and Toxicity-Removing Formulations was obvious without adverse reactions, and it may take the role through regulating the hormones level .
机构地区 银川市中医医院
出处 《中国皮肤性病学杂志》 CAS 北大核心 2010年第6期568-569,572,共3页 The Chinese Journal of Dermatovenereology
关键词 清肺利湿解毒方药 寻常性痤疮 性激素 Lung-Clearing, Dampness-Eliminating and Toxicity-Removing Formulations Ache Valgaris Sexhormone
  • 相关文献

参考文献5

二级参考文献19

  • 1鞠强,夏隆庆,尹兴平,陈沄,石继海.盐酸小檗碱、黄芩苷和苦参碱对SZ95皮脂腺细胞增殖及脂质合成的影响[J].中华皮肤科杂志,2005,38(11):662-664. 被引量:14
  • 2弓娟琴.痤疮与雄激素关系的研究进展[J].国外医学(皮肤性病学分册),1997,23(2):65-68. 被引量:46
  • 3赵辨.临床皮肤病学[M].南京:江苏科技出版社,1988.252-254.
  • 4中华人民共和国卫生部.中药新药临床研究指导原则(第三辑)[M].北京:人民卫生出版社,2002:292.
  • 5Cooper A J. Systematic review of propionibacterium acnes resistance to systemic antibiotics[J]. Med J Aust, 1998,169: 259-261.
  • 6朱文锋.中医主证鉴别诊疗学[M].长沙:湖南科技出版社,2000.316-331
  • 7Ott F, Bollag H, geiger JM. Oral 9-cis-retinoic versus 13-cis-retinoic in acne therapy. Dermatol, 1996,193: 124.
  • 8Jones H, Blanc D, Cunliffe WJ et al. 13-cis retinoic in acid and aerie. Lancet, 1980,10:1048.
  • 9Sitzmann JH, Bauer FW, Cunliffe WJ, et al. In sithybridization analysis of CRABP Ⅱ expresion in sebaceous follicles from 13 - cis retinoic aid-treated acne patients. Br J Dermatol, 1995,133:241.
  • 10隋·巢元方.诸病源候论[M].沈阳:辽宁科技出版社,1997.133.

共引文献97

同被引文献69

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部